Tresiba® U-100 is the only basal insulin indicated for type 1 and type 2 diabetes in children as young as 1 year of age.1-5 See guidance below on how to start or convert your pediatric patients to once-daily Tresiba®.
Prescribing Tresiba® to pediatric patients
For pediatric patients with type 1 and type 2 diabetes already taking insulin

START
Tresiba® at 80% of the current dose of basal insulin to minimize the risk of hypoglycemia

INJECT
Once daily at the same time of day

TITRATE
Every 3 to 4 days as needed
- If a pediatric patient misses a dose, they should contact their health care provider for guidance and monitor blood glucose levels more frequently until the next scheduled dose1
- Individualize the dose according to the patient’s metabolic needs, blood glucose monitoring results, and glycemic control goals, with 3 to 4 days between each dose increase1
For insulin-naïve adult and pediatric patients with type 1 diabetes
CALCULATE
total daily insulin dose (basal + bolus)
0.2 to 0.4
units per kg of body weight

START
initial Tresiba® dose at
1/3 to 1/2
of total daily insulin dose
- The recommended starting dose of Tresiba® in insulin-naïve pediatric and adult patients with type 2 diabetes is 10 units once daily
- Adults already taking insulin can start on the same unit dose as their current basal insulin and take their injection at any time of day
- Adult patients who miss a dose of Tresiba® should inject their daily dose during waking hours upon discovering the missed dose, then continue with their regular dosing schedule. Ensure that at least 8 hours have elapsed between Tresiba® injections

Add Tresiba® to your electronic prescribing system
Tresiba® FlexTouch® U-100

NDC:
0169-2660-15
Form/Strength:
100 U/mL
Quantity per box:
5 pens
15 mL (5 x 3 mL)
1500 units total
Tresiba® U-100, 10-mL vial

NDC:
0169-2662-11
Form/Strength:
100 U/mL
Quantity per box:
1 vial
10 mL
1000 units total
